APR

About:

APR is a developer of a generic version of the drug Premarin.

Description:

APR is a developer of a generic version of the drug Premarin which is a hormone replacement drug for women. All assets, liabilities, and intellectual property of APR were acquired by Dr. Reddy's Laboratories (New York) on July 11, 2011.

Total Funding Amount:

$8.78M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Upper Saddle River, New Jersey, United States

Founded Date:

Founders:

Number of Employees:

101-250

Last Funding Date:

2009-05-05

IPO Status:

Private

Industries: